Clariant TEA extension
This article was originally published in The Rose Sheet
Executive Summary
FDA grants piroctone olamine manufacturer's request for extension of public comment period for anti-dandruff ingredient safety and efficacy review to August 16. In a May 19 Federal Register 1notice, the agency said it "considers an extension of time for submission of data, information and general comments concerning the safety and effectiveness of piroctone olamine to be in the public interest." Clariant had requested the 90-day extension to assemble a "more comprehensive" submission for the ingredient in an April 16 letter to FDA (2"The Rose Sheet" May 10, 2004, In Brief)...